1. BerkhoutJ MelchersMJ SeyedmousaviS LagardeCM SchuckV NicholsWW et al. (2013).Exposure response relationships of ceftazidime and avibactam in a neutropenic thigh model. 53rd Intersceince Conference on Antimicrobial Agents and Chemotherapy 2013 Denver CO USA.
2. 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
3. Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam
4. Food and Drug Administration(2012).Guidance for industry: Drug Interaction Studies ‐ study design data analysis implications for dosing and labeling recommendations. Available athttp://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292362.pdf. (accessed 12 June 2015).
5. Food and Drug Administration(2015).AVYCAZ (ceftazidime–avibactam) for injection for intravenous use: highlights of prescribing information. Available athttp://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206494s000lbl.pdf. (accessed 12 June 2015).